federal_register: 2015-31690
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-31690 | Safety Assessment for Investigational New Drug Application Safety Reporting; Draft Guidance for Industry; Availability | Notice | The Food and Drug Administration (FDA, we, or Agency) is announcing the availability of a draft guidance for industry entitled "Safety Assessment for IND Safety Reporting." The draft guidance provides recommendations to sponsors on developing a systematic approach to investigational new drug application (IND) safety reporting for human drugs and biological products developed under an IND. This draft guidance is a follow-on to the guidance for industry and investigators entitled "Safety Reporting Requirements for INDs and BA/ BE Studies" that provides recommendations for how sponsors of INDs can identify and evaluate important safety information that must be submitted to FDA and all participating investigators, including a recommendation that sponsors develop a safety assessment committee. | 2015-12-17 | 2015 | 12 | https://www.federalregister.gov/documents/2015/12/17/2015-31690/safety-assessment-for-investigational-new-drug-application-safety-reporting-draft-guidance-for | https://www.govinfo.gov/content/pkg/FR-2015-12-17/pdf/2015-31690.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA, we, or Agency) is announcing the availability of a draft guidance for industry entitled "Safety Assessment for IND Safety Reporting." The draft guidance provides recommendations to sponsors on developing a... |